Daily yogurt consumption may decrease risk of type 2 diabetes
the ONA take:
According to a new study published in the journal BMC Medicine, researchers at the Harvard School of Public Health in Boston, Massachusetts, have found that a higher intake of yogurt decreases the risk of developing type 2 diabetes.
For the study, researchers sought to investigate the association between total and certain types of dairy consumption and the incidence of type 2 diabetes in adults. The researchers analyzed data from three cohort studies that only included health care professionals. They identified 194,519 participants eligible for this study.
All participants had completed a health and lifestyle questionnaire at the beginning of the study and were followed up with every 2 years to complete further questionnaires. No participants had cancer, cardiovascular disease, or diabetes when the study started.
During the follow-up period, researchers identified 15,156 cases of type 2 diabetes and found no link between total dairy consumption and the development of type 2 diabetes; however, there was an association between high yogurt consumption and a decreased risk for developing type 2 diabetes.
The study determined that consuming 28 grams of yogurt per day decreased the risk for developing type 2 diabetes by 18%. The researchers note that randomized clinical trials are required to further assess the association.
A higher intake of yogurt decreases the risk of developing type 2 diabetes.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|